Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Curr Osteoporos Rep. 2015 Oct;13(5):342–350. doi: 10.1007/s11914-015-0285-9

Table 1.

Osteogenic differentiation of embryonic stem cells.

Embryoid
body (EB) vs
monolayer
(ML)
Factors
tested
Additional
conditions
(eg
bioreactor)
Assays (mineral deposition, gene
expression, implant)
Reference
Mouse
EB AA, βGP, dex
  • Mineral deposition

  • Immunostaining for osteocalcin

(5)
EB AA, βGP, RA,
BMP2
  • Mineral deposition

  • Osteogenic marker expression

(70)
EB AA, βGP, VD3
  • Mineral deposition

  • Osteogenic marker expression

  • ALP activity

(22)
EB AA, βGP, dex
  • Osteogenic marker expression

  • Microarray

  • Mineral deposition

(20)
EB AA, βGP,
VD3, RA,
BMP2
  • Osteogenic marker expression

  • Microarray

  • Mineral deposition

(23)
ESCs seeded
on scaffold to
form cartilage
matrix
  • Healing of rat critical-size cranial defect

(25)
EB AA, βGP, dex Decellularized
osteogenic
extracellular
matrix
  • Mineral deposition

  • Osteogenic marker expression

(26)
ML AA, βGP, dex CultiSpher S
microcarrier
  • Osteogenic marker expression

  • Mineral deposition

  • Subcutaneous implant in SCID mice

  • Healing of burr-hole fracture in mice

(29)
EB AA, βGP, dex
  • Mineral deposition

  • Osteogenic marker expression

  • Compared to BMSCs and calvarial osteoblasts

(88)
EB AA, βGP, VD3 3D type I
collagen gel
  • Healing of burr-hole fracture in mice

(30)
EB AA, βGP, dex,
PPARγ
inhibitor, RA
  • Mineral deposition

  • Osteogenic marker expression

  • Immunostaining for Runx2, osterix

(89)
EB AA, βGP, VD3 Cyclic loading
  • Osteogenic marker expression

(32)
EB AA, βGP, dex,
BMP4
  • Osteogenic marker expression

(21)
Human
EB AA, βGP, dex
  • Mineral deposition

  • Osteogenic marker expression

(18)
EB AA, βGP, dex
  • Mineral deposition

  • Osteogenic marker expression

  • Subcutanoue implant in SCID mice on PDLLA scaffold

(19)
ML Various HA/TCP
particles or
carpet
  • Osteogenic marker expression

  • Subcutaneous implant in immunodeficient mice

  • Teratoma formation

(31)
EB Lentiviral
expression of
Runx2 and
BMP-2-
enriched
hydrogel
  • Osteogenic marker expression

  • Immunostaining for osteocalcin and type I collagen

  • Mineral deposition

  • Subcutaneous implant in immunodeficient mice

(90)
ML AA, βGP, dex Decellularized
bone scaffolds
and perfused
bioreactor
culture
  • Immunostaining for osteocalcin

  • Subcutaneous implant in immunodeficient mice

(27)
ML AA, βGP, dex Mechanical
strain on
BioFlex plates
  • Immunostaining for osteocalcin and type I collagen

  • Mineral deposition

  • Osteogenic marker expression

(33)
ML AA, βGP Decellularized
osteogenic
matrix on
PLGA scaffold
  • Mineral deposition

  • Immunostaining for osteocalcin

  • Osteogenic marker expression

(28)
ML Zinc finger
nuclease
targeting of
Col2.3GFP
and
hydroxyapatite
/collagen
matrix scaffold
  • Teratoma formation

  • Implant into mouse calvarial defect model

(24)

Abbreviations: AA – ascorbic acid; βGP – β-glycerophosphate; RA – retinoic acid; VD3 – 1,25OH-vitamin D3; PDLLA – poly-D, L-lactide; ALP – alkaline phosphatase; BMSC – bone marrow stromal cell; PLGA – poly(lactic-co-glycolic acid); HA/TCP – hydroxyapatite/tricalcium phosphate